


BIONOXX Revenue
Pharmaceutical Manufacturing • Seoul, Korea, Republic of • 11-20 Employees
BIONOXX revenue & valuation
| Annual revenue | $1,112,215 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $3,600,000 |
| Total funding | No funding |
Key Contact at BIONOXX
Dujin Kim
Executive Director
Company overview
| Headquarters | Seoul, Korea, Republic of |
| Phone number | +82317199179 |
| Website | |
| NAICS | 3254 |
| Keywords | Immuno-Oncology, Immunotherapy, Gene And Cell Therapy, T Cell Modulation, Neutrophil-Directed Modulation, Viral Sepsis |
| Founded | 2016 |
| Employees | 11-20 |
| Socials |
BIONOXX Email Formats
BIONOXX uses 1 email format. The most common is {last name} (e.g., doe@pusan.ac.kr), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{last name} | doe@pusan.ac.kr | 100% |
About BIONOXX
Bionoxx is an innovative biotechnology company pioneering neutrophil-directed T cell modulation to fight cancer and immune disorders. Our team of experts is dedicated to tailoring immunotherapies based on a novel analytical method, to improve clinical outcome for patients. Follow us for groundbreaking advancements and industry collaborations.
Employees by Management Level
Total employees: 11-20
Seniority
Employees
Employees by Department
BIONOXX has 3 employees across 3 departments.
Departments
Number of employees
Funding Data
BIONOXX has never raised funding before.
Frequently asked questions
4.8
40,000 users



